BMS SCLC Chances Dive After Opdivo, Yervoy Combo Flunks Checkmate-451

 
• By Sten Stovall
  
Lung cancer
Bristol-Myers Squibb's Checkmate-451 Tested Opdivo and Yervoy in Small cell Lung Cancer • Source: Shutterstock

More from Clinical Trials

More from R&D